What is the outcome of RA in 2011 and can we predict it?

Best Practice and Research: Clinical Rheumatology

Volumn 25, Issue 4, 2011, Pages 485-496

  Verstappen, Suzanne M M ^a   Symmons, Deborah P M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Outcome; Predictors; Rheumatoid arthritis; Trends

Indexed keywords

AUTOANTIBODY;

AGE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COMORBIDITY; DIABETES MELLITUS; DISABILITY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; EYE DISEASE; GENDER; GENETIC MARKER; HUMAN; INCIDENCE; INTERSTITIAL LUNG DISEASE; JOINT RADIOGRAPHY; MORTALITY; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDITIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REMISSION; RESPIRATORY TRACT DISEASE; RHEUMATOID ARTHRITIS; RHEUMATOID VASCULITIS; RISK FACTOR; SMOKING; TREATMENT RESPONSE;

EID: 82955237772     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2011.10.008     Document Type: Review

References (73)

1. D.T. Felson, J.J. Anderson, and M. Boers The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The committee on outcome measures in rheumatoid arthritis clinical trials Arthritis and Rheumatism 36 6 1993 Jun 729 740 (Pubitemid 23175613)
2. D.M. van der Heijde, M. van 't Hof, and P.L. van Riel Development of a disease activity score based on judgment in clinical practice by rheumatologists Journal of Clinical Rheumatology 20 3 1993 Mar 579 581 (Pubitemid 23102498)
3. M.L. Prevoo, M.A. 't Hof, and H.H. Kuper Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis and Rheumatism 38 1 1995 Jan 44 48
4. J. Fransen, M.C. Creemers, and P.L. van Riel Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria Rheumatology (Oxford) 43 10 2004 Oct 1252 1255 (Pubitemid 39359299)
5. D.T. Felson, J.S. Smolen, and G. Wells American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials Arthritis and Rheumatism 63 3 2011 Mar 573 586
6. A. Silman, P. Davies, and H.L. Currey Is rheumatoid arthritis becoming less severe? Journal of Chronic Disease 36 12 1983 891 897 (Pubitemid 14204672)
7. T. Pincus, T. Sokka, and H. Kautiainen Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985 Arthritis and Rheumatism 52 4 2005 Apr 1009 1019 (Pubitemid 40530106)
8. P.M. Welsing, J. Fransen, and P.L. van Riel Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis Arthritis and Rheumatism 52 9 2005 Sep 2616 2624 (Pubitemid 41369089)
9. K.L. Hyrich, K.D. Watson, and M. Lunt Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008 Rheumatology (Oxford) 50 1 2011 Jan 117 123
10. J.F. Fries, P. Spitz, and R.G. Kraines Measurement of patient outcome in arthritis Arthritis and Rheumatism 23 2 1980 Feb 137 145 (Pubitemid 10164318)
11. E. Tanaka, A. Mannalithara, and E. Inoue Efficient management of rheumatoid arthritis significantly reduces long-term functional disability Annals of Rheumatic Diseases 67 8 2008 Aug 1153 1158
12. J.R. Kirwan, and J.S. Reeback Stanford Health Assessment questionnaire modified to assess disability in British patients with rheumatoid arthritis Journal of Rheumatology 25 1986 206 209 (Pubitemid 16033804)
13. C.A. Scire, S.M. Verstappen, and H. Mirjafari Reduction of long-term disability in inflammatory polyarthritis by early and persistent suppression of joint inflammation: Results from the Norfolk Arthritis Register Arthritis Care Res (Hoboken) 63 7 2011 Jul 945 952
14. D. Aletaha, J. Smolen, and M.M. Ward Measuring function in rheumatoid arthritis: Identifying reversible and irreversible components Arthritis and Rheumatism 54 9 2006 Sep 2784 2792 (Pubitemid 44497757)
15. E. Krishnan, and J.F. Fries Reduction in long-term functional disability in rheumatoid arthritis from 1977 to 1998:a longitudinal study of 3035 patients American Journal of Medicine 115 5 2003 Oct 1 371 376 (Pubitemid 37311254)
16. T. Pincus, J.A. Summey, and S.A. Soraci Jr. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire Arthritis and Rheumatism 26 11 1983 Nov 1346 1353 (Pubitemid 14231480)
17. T. Sokka, H. Kautiainen, and P. Hannonen Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population Arthritis and Rheumatism 54 10 2006 Oct 3113 3118 (Pubitemid 44622080)
18. E.M. Camacho, S.M.M. Verstappen, M. Lunt, D.K. Bunn, and D.P.M. Symmons The influence of age and gender on functional outcome over time in a cohort of patients with recent onset inflammatory polyarthritis (noar): women and patients aged 75 and over at symptom onset have the worst prognosis Arthritis Care Res (Hoboken) 2011 [Epub ahead]
19. H. Radner, J.S. Smolen, and D. Aletaha Impact of comorbidity on physical function in patients with rheumatoid arthritis Annals of Rheumatic Diseases 69 3 2010 Mar 536 541
20. T. Sokka, H. Kautiainen, and A. Hakkinen Radiographic progression is getting milder in patients with early rheumatoid arthritis. Results of 3 cohorts over 5 years Journal of Rheumatology 31 6 2004 Jun 1073 1082 (Pubitemid 38715880)
21. A. Finckh, H.K. Choi, and F. Wolfe Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment Annals of Rheumatic Diseases 65 9 2006 Sep 1192 1197 (Pubitemid 44277395)
22. R.A. Watts, D.M. Carruthers, and D.P. Symmons The incidence of rheumatoid vasculitis in the Norwich Health Authority British Journal of Rheumatology 33 9 1994 Sep 832 833 (Pubitemid 24283221)
23. C. Turesson, R.L. McClelland, and T.J. Christianson No decrease over time in the incidence of vasculitis or other extraarticular manifestations in rheumatoid arthritis: results from a community-based study Arthritis and Rheumatism 50 11 2004 Nov 3729 3731 (Pubitemid 39488703)
24. R.A. Watts, J. Mooney, and S.E. Lane Rheumatoid vasculitis: becoming extinct? Rheumatology (Oxford) 43 7 2004 Jul 920 923 (Pubitemid 38996969)
25. C. Bartels, C. Bell, and A. Rosenthal Decline in rheumatoid vasculitis prevalence among US veterans: a retrospective cross-sectional study Arthritis and Rheumatism 60 9 2009 Sep 2553 2557
26. G. Koduri, S. Norton, and A. Young Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort Rheumatology (Oxford) 49 8 2010 Aug 1483 1489
27. J.P. Fuld, M.K. Johnson, and M.M. Cotton A longitudinal study of lung function in nonsmoking patients with rheumatoid arthritis Chest 124 4 2003 Oct 1224 1231 (Pubitemid 37290030)
28. C.M. Bartels, C.L. Bell, and K. Shinki Changing trends in serious extra-articular manifestations of rheumatoid arthritis among United State veterans over 20 years Rheumatology (Oxford) 49 9 2010 Sep 1670 1675
29. J.M. Kremer, G.S. Alarcon, and M.E. Weinblatt Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review Arthritis and Rheumatism 40 10 1997 Oct 1829 1837 (Pubitemid 27452534)
30. C. Salliot, and D. van der Heijde Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research Annals of Rheumatic Diseases 68 7 2009 Jul 1100 1104
31. S.M. Verstappen, M.F. Bakker, and A.H. Heurkens Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study Annals of Rheumatic Diseases 69 6 2010 Jun 1044 1048
32. W.G. Dixon, K.L. Hyrich, and K.D. Watson Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register Annals of Rheumatic Diseases 69 6 2010 Jun 1086 1091
33. J.F. Boyer, P.A. Gourraud, and A. Cantagrel Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis Joint Bone Spine 78 2 2011 Mar 179 183
34. D.P. Symmons, and S.E. Gabriel Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE Nature Reviews Rheumatology 7 7 2011 399 408
35. N.J. Goodson, N.J. Wiles, and M. Lunt Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients Arthritis and Rheumatism 46 8 2002 Aug 2010 2019
36. H. Maradit-Kremers, C.S. Crowson, and P.J. Nicola Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study Arthritis and Rheumatism 52 2 2005 Feb 402 411 (Pubitemid 40220344)
37. P.J. Nicola, H. Maradit-Kremers, and V.L. Roger The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years Arthritis and Rheumatism 52 2 2005 Feb 412 420 (Pubitemid 40216304)
38. M.J. Peters, D.P. Symmons, and D. McCarey EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis Annals of Rheumatic Diseases 69 2 2010 Feb 325 331
39. A.L. Smitten, T.A. Simon, and M.C. Hochberg A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis Arthritis Res Ther 10 2 2008 R45
40. D. Hoshi, A. Nakajima, and E. Inoue Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab Modern and Rheumatology 2011 Jul 8
41. G.V. Ruiz, P. Jobanputra, and A. Burls Certolizumab pegol (CDP870) for rheumatoid arthritis in adults Cochrane Database Syst Rev 2 2011 CD007649
42. J.A. Avina-Zubieta, H.K. Choi, and M. Sadatsafavi Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies Arthritis and Rheumatism 59 12 2008 Dec 15 1690 1697
43. C. Meune, E. Touze, and L. Trinquart Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies Rheumatology (Oxford) 48 10 2009 Oct 1309 1313
44. A. Gonzalez, K.H. Maradit, and C.S. Crowson The widening mortality gap between rheumatoid arthritis patients and the general population Arthritis and Rheumatism 56 11 2007 Nov 3583 3587 (Pubitemid 350100691)
45. D. Krause, B. Schleusser, and G. Herborn Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis Arthritis and Rheumatism 43 1 2000 Jan 14 21 (Pubitemid 30368208)
46. H.K. Choi, M.A. Hernan, and J.D. Seeger Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study Lancet 359 9313 2002 Apr 6 1173 1177 (Pubitemid 34304256)
47. L.T. Jacobsson, C. Turesson, and J.A. Nilsson Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis Annals of Rheumatic Diseasess 66 5 2007 May 670 675 (Pubitemid 46707138)
48. J.J. Goronzy, E.L. Matteson, and J.W. Fulbright Prognostic markers of radiographic progression in early rheumatoid arthritis Arthritis and Rheumatism 50 1 2004 Jan 43 54 (Pubitemid 38084286)
49. D. Aletaha, T. Neogi, and A.J. Silman 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Annals of Rheumatic Diseases 69 9 2010 Sep 1580 1588
50. T.M. Farragher, M. Lunt, and B. Fu Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis Annals of Rheumatic Diseases 69 4 2010 Apr 689 695
51. I. Goetz, G.C. Carter, and M. Lucero Review of treatment response in rheumatoid arthritis: assessment of heterogeneity Current Medical Research and Opinion 27 4 2011 Apr 697 711
52. J.J. Anderson, G. Wells, and A.C. Verhoeven Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration Arthritis and Rheumatism 43 1 2000 Jan 22 29 (Pubitemid 30368209)
53. J.A. Karlsson, L.E. Kristensen, and M.C. Kapetanovic Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register Rheumatology (Oxford) 47 4 2008 Apr 507 513
54. B. Masdottir, T. Jonsson, and V. Manfredsdottir Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis Rheumatology (Oxford) 39 11 2000 Nov 1202 1205
55. S. Saevarsdottir, S. Wedren, and M. Seddighzadeh Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohorts Arthritis and Rheumatism 63 1 2011 Jan 26 36
56. K.L. Hyrich, K.D. Watson, and A.J. Silman Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register Rheumatology (Oxford) 45 12 2006 Dec 1558 1565 (Pubitemid 44817065)
57. T.M. Farragher, N.J. Goodson, and H. Naseem Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis Arthritis and Rheumatism 58 2 2008 Feb 359 369 (Pubitemid 351294870)
58. S.M. Naz, T.M. Farragher, and D.K. Bunn The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis Arthritis and Rheumatism 58 4 2008 Apr 985 989 (Pubitemid 351563999)
59. T.M. Farragher, M. Lunt, and D. Plant Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies Arthritis Care and Research (Hoboken) 62 5 2010 May 664 675
60. S.M. Verstappen, M. Lunt, and D.K. Bunn In patients with early inflammatory polyarthritis, ACPA positivity, younger age and inefficacy of the first non-biological DMARD are predictors for receiving biological therapy: results from the Norfolk Arthritis Register Annals of Rheumatic Diseases 70 8 2011 Aug 1428 1432
61. T. Mottonen, L. Paimela, and M. Leirisalo-Repo Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy Annals of Rheumatic Diseases 57 9 1998 Sep 533 539 (Pubitemid 28474060)
62. O. Meyer, C. Labarre, and M. Dougados Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage Annals of Rheumatic Diseases 62 2 2003 Feb 120 126 (Pubitemid 36135386)
63. M. Bukhari, W. Thomson, and H. Naseem The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register Arthritis and Rheumatism 56 9 2007 Sep 2929 2935 (Pubitemid 47502739)
64. J.K. de Vries-Bouwstra, Y.P. Goekoop-Ruiterman, and K.N. Verpoort Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies Arthritis and Rheumatism 58 5 2008 May 1293 1298 (Pubitemid 351705918)
65. J.J. Luime, E.M. Colin, and J.M. Hazes Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review Annals of Rheumatic Diseases 69 2 2010 Feb 337 344
66. D. Plant, W. Thomson, and M. Lunt The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register Rheumatology (Oxford) 50 1 2011 Jan 78 84
67. J.A. Wessels, W.M. Kooloos, and J.R. De Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis Arthritis and Rheumatism 54 9 2006 Sep 2830 2839 (Pubitemid 44497761)
68. C. Potter, H.J. Cordell, and A. Barton Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways Annals of Rheumatic Diseases 69 7 2010 Jul 1315 1320
69. R.J. Tan, L.J. Gibbons, and C. Potter Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment Annals of Rheumatic Diseases 69 6 2010 Jun 1029 1035
70. E.A. Haavardsholm, P. Boyesen, and M. Ostergaard Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression Annals of Rheumatic Diseases 67 6 2008 Jun 794 800 (Pubitemid 351843277)
71. A. Skapenko, I. Prots, and H. Schulze-Koops Prognostic factors in rheumatoid arthritis in the era of biologic agents Nature Reviews Rheumatology 5 9 2009 Sep 491 496
72. D.A. Pappas, J.T. Giles, and G. Connors Respiratory symptoms and disease characteristics as predictors of pulmonary function abnormalities in patients with rheumatoid arthritis: an observational cohort study Arthritis Research and Therapy 12 3 2010 R104
73. S.M. Verstappen, W.G. Dixon, J. Chipping, M. Lunt, and D. Symmons Obstructive and restrictive lung disease in patients with inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR) Annals of Rheumatic Diseases 70 Suppl 3 2011 123 Ref Type: Abstract